Drugmaker Pfizer Inc. has been aggressively attacking the experts the plaintiffs want to use to show a causal relationship between Zoloft and birth defects. Now the battle over those experts has moved into the courtroom, with hearings this week in Philadelphia on the admissibility of their opinions.
Anick Bérard, a perinatal epidemiologist who studies babies’ exposure to drugs before they are born, has received the most extensive attention from Pfizer’s lawyers.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
